Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.243ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
R.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.216ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.471ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.420ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
L.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.518ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.551ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.207ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.604ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.111ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.619ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.23.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.316ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.436ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.558ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.518ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.368ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.404ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.306ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.328ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.533ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KC.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KL.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.507ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.54ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.196ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.459ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.117ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.381ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.237ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.382ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.395ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.153ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used